IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first three months 2026 results.
HIGHLIGHTS
- Revenue at EUR 1,267 million (+6% on a constant currency basis)
- Gross profit at EUR 312 million (+1% on a constant currency basis)
- Operating EBITA at EUR 130 million (-2% on a constant currency basis)
- Free cash flow up by 19% to EUR 121 million (first three months 2025: EUR 102 million)
- Cash earnings per share at EUR 1.46 (first three months 2025: EUR 1.55)
- Completion of the acquisitions of Dong Yang FT (South Korea) and Willows Ingredients (Ireland)
Marcus Jordan, CEO: "We have delivered a solid Q1, against strong Q1 2025 comparables, with increased free cash flow and a robust cash conversion margin. Global uncertainty persists, further intensified by the recent conflict in the Middle East, and in these challenging times it is critical to remain a reliable partner for both customers and suppliers. Supported by our diversified business model and advanced digital and supply chain management capabilities, we will continue to create value for our stakeholders."
